BIOPHEN™ Anti-Xa 2-Stage Heparin Assay — USP/EP Compliant
Processing...

BIOPHEN™ Anti-Xa 2-Stage Heparin Assay — USP/EP Compliant

Code: A221005
Manufacturer’s Part Number: 221005
Product size: Kit
Clearance: RUO

Price: $593.00

Qty

Product Description

Two-stage chromogenic anti-Xa method for measuring heparin activity (UFH or LMWH) in the presence of a constant amount of antithrombin (AT), in compliance with pharmacopoeias. For heparin testing in human citrated plasma or purified solutions.

Meets USP and European Pharmacopoeia (EP) requirements for heparin potency testing.

  • Two-stage method: Factor Xa inhibited by heparin + AT; residual FXa measured by substrate SXa-11
  • Validated for pharmacopoeia compliance testing of heparin raw materials

Product Characteristics

Product Components

  • R1: 2 x 1 mL ATIII(h)
  • R2: 2 x 1 mL FXa(b)
  • R3: 2 x 1 mL Factor Xa specific chromogenic substrate

Product Applications

For the measurement of anti-Xa Heparin activity in research applications.

This assay, using a predilution of Antithrombin and FXa reagents in specific buffers (not provided within this kit), is in compliance with the US Pharmacopoeia (USP 40:2017) and European Pharmacopoeia (EP 9th edition 2017).

Please Note: Results obtained should be for research purposes only and not used for patient diagnosis or treatment.

Instructions For Use

Material Safety Data Sheet (MSDS)

Data Sheet/Technical Data

Other Documents